Searacare Life Sciences, Inc. (SRLS)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
1935 AVENIDA DEL ORO OCEANSIDE, CA 92056

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

SeraCare Life Sciences, Inc. is a manufacturer and provider of biological products and services for diagnostic, therapeutic, drug discovery and research organizations. It is a vendor-approved supplier to over 500 pharmaceutical and healthcare companies. Through strategic alliances with Biomat USA, Inc., the Company has access to a nationwide network of donor centers. Through its alliance with Proliant, Inc., the Company has access to bovine serum albumin, which has provided the basis for development of its bovine serum-based products. It also provides antibody-based products, which are used as active ingredients in therapeutic products (generally, drugs used to treat and manage diseases) and in diagnostic products (generally, diagnostic tests and test kits). In September 2004, the Company acquired BBI Diagnostics and BBI Biotechnology Research Laboratories divisions of Boston Biomedica, Inc. It also acquired substantially all of the assets of Genomics Collaborative, Inc.

View SEC Filings from SRLS instead.

View recent insider trading info

Funds Holding SRLS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SRLS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HRUSOVSKY E KEVIN

  • Director
0 2012-04-20 0

GOULD GREGORY A INTERIM CEO, CFO, TREAS & SEC.

  • Officer
0 2012-04-20 0

NEMMERS JOSEPH M

  • Director
No longer subject to file 2012-04-20 0

MCLAIN BRIAN VP, FINANCE AND CONTROLLER

  • Officer
No longer subject to file 2012-04-20 0

DILLING RONALD VP, OPERATIONS

  • Officer
No longer subject to file 2012-04-20 0

BENJAMIN KATHLEEN VP, HUMAN RESOURCES

  • Officer
No longer subject to file 2012-04-20 0

OLSEN DAVID VP, CORPORATE QUALITY

  • Officer
No longer subject to file 2012-04-20 0

SHEA KATHERYN VP, BIOSERVICES

  • Officer
No longer subject to file 2012-04-20 0

TILLMAN JILL

  • Director
No longer subject to file 2012-04-20 0

MURPHY SARAH L

  • Director
No longer subject to file 2012-04-20 0

O'CONNOR JOHN J. II VP, SALES AND MARKETING

  • Officer
No longer subject to file 2012-04-20 0

VOGT SUSAN L N PRESIDENT, CEO & DIRECTOR

  • Officer
  • Director
190,080 2011-05-25 0

ANDERSON SAMUEL

  • Director
244,206 2011-04-04 0

DAVIS EUGENE I

  • Director
20,073 2011-04-01 0

BLUE HAROLD S

  • Director
12,594 2011-04-01 0

STEELE MICHAEL K V.P., BUSINESS DEVELOPMENT

  • Officer
25,239 2010-12-08 0

KEEFE SUSAN DIR. OF FINANCE & COMPLIANCE

  • Officer
8,400 2010-12-08 0

SMUTNY WILLIAM V.P., SALES & MARKETING

  • Officer
11,166 2010-04-01 0

MANAK MARK CHIEF SCIENTIST

  • Officer
7,358 2009-11-18 0

SAFIER JACOB

LTOVA HOLDINGS LLC

  • 10% Owner
3,853,263 2009-02-24 0

HARBINGER CAPITAL PARTNERS MASTER FUND I, LTD.

HARBINGER CAPITAL PARTNERS OFFSHORE MANAGER, L.L.C.

HMC INVESTORS, L.L.C.

HARBINGER CAPITAL PARTNERS SPECIAL SITUATIONS FUND, L.P.

HARBINGER CAPITAL PARTNERS SPECIAL SITUATIONS GP, LLC

HMC - NEW YORK, INC.

HARBERT MANAGEMENT CORP

FALCONE PHILIP

HARBERT RAYMOND J

LUCE MICHAEL D

  • 10% Owner
  • *SEE REMARKS*SEE REMARKS*SEE REMARKS*SEE REMARKS*SEE REMARKS*SEE REMARKS*SEE REMARKS*SEE REMARKS*SEE REMARKS*SEE REMARKS
No longer subject to file 2009-02-23 0

HARBINGER CAPITAL PARTNERS SPECIAL SITUATIONS FUND, L.P.

HARBINGER CAPITAL PARTNERS SPECIAL SITUATIONS GP, LLC

HMC - NEW YORK, INC.

HARBERT MANAGEMENT CORP

FALCONE PHILIP

HARBERT RAYMOND J

LUCE MICHAEL D

  • 10% Owner
  • *SEE REMARKS*SEE REMARKS*SEE REMARKS*SEE REMARKS*SEE REMARKS*SEE REMARKS*SEE REMARKS
3,949,370 2009-01-20 0

HARBINGER CAPITAL PARTNERS SPECIAL SITUATIONS FUND, L.P.

HARBINGER CAPITAL PARTNERS SPECIAL SITUATIONS GP, LLC

HMC - NEW YORK, INC.

  • 10% Owner
  • *SEE REMARKS*SEE REMARKS*SEE REMARKS
650,529 2009-01-15 0

TENG NELSON

  • FORMER DIRECTOR
0 2007-05-17 0

CRESCI ROBERT J

  • FORMER DIRECTOR
0 2007-05-17 0

HARBINGER CAPITAL PARTNERS MASTER FUND I, LTD.

HARBINGER CAPITAL PARTNERS OFFSHORE MANAGER, L.L.C.

HMC INVESTORS, L.L.C.

HARBERT MANAGEMENT CORP

FALCONE PHILIP

HARBERT RAYMOND J

LUCE MICHAEL D

  • 10% Owner
4,321,372 2007-05-17 0

JALLAD EZZAT

  • FORMER DIRECTOR
0 2007-05-17 0

KASTEN BERNARD L

  • FORMER DIRECTOR
0 2007-05-17 0

BL CUBED LLC

LEVITIN RAIZY

LEVITIN ELI

LEVITIN FAMILY CHARITABLE TRUST

  • SEE REMARK 1SEE REMARK 1SEE REMARK 1SEE REMARK 1
96,786 2007-05-17 0

NEW DIMENSIONS TRADING

  • SEE REMARK 1
248,142 2007-05-17 0

CHESED CONGREGATIONS OF AMERICA

  • SEE REMARK 1
290,991 2007-05-17 0

SAFIER JACOB

  • SEE REMARK 1
112,606 2007-05-17 0

LIVINGSTONE JEFF V.P., BUSINESS DEVELOPMENT

  • Officer
0 2007-05-17 0

BLACK HORSE CAPITAL ADVISORS LLC

BLACK HORSE CAPITAL OFFSHORE LTD.

BLACK HORSE CAPITAL LP

BLACK HORSE CAPITAL QP L P

BLACK HORSE CAPITAL MANAGEMENT LLC

SHEEHY BRIAN

CHAPPELL DALE

  • SEE (1)(2)SEE (1)(2)SEE (1)(2)SEE (1)(2)SEE (1)(2)SEE (1)(2)SEE (1)(2)
1,041,850 2006-11-10 0

HARBERT MANAGEMENT CORP

FALCONE PHILIP

HARBERT RAYMOND J

LUCE MICHAEL D

  • 10% Owner
2,962,934 2006-10-04 0

LAWLOR THOMAS F GLOBAL CHIEF OPERATING OFFICER

  • Officer
160,000 2006-05-26 0

LOW CATHRYN INTERIM CFO

  • Officer
0 2006-04-04 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments